Back
Mithra Pharmaceuticals SA Quote, Financials, Valuation and Earnings
Write This Down: Tuesday at 2 p.m. ET!
Don't Miss Our LIVE Trade
Sell
23
MITPF
Mithra Pharmaceuticals SA
Last Price:
6.75
Seasonality Move:
0.54%
7 Day Trial
ALL ACCESS PASS
$
7
The Mysterious VC Firm Behind Nvidia's Secret Weapon
Details Here!Mithra Pharmaceuticals SA Price Quote
$6.75
Mithra Pharmaceuticals SA Key Stats
Sell
23
Mithra Pharmaceuticals SA (MITPF)
is a Sell
Day range:
$6.75 - $6.75
52-week range:
$6.75 - $6.75
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
0%
Volume:
0
Avg. volume:
0
1-year change:
0%
Market cap:
$451.6M
Revenue:
$70.7M
EPS:
$-1.5
How Much Does Mithra Pharmaceuticals SA Make?
-
How Much Are Mithra Pharmaceuticals SA's Sales Annually?
MITPF Revenues are $70.7M -
How Much Profit Does Mithra Pharmaceuticals SA's Make A Year?
MITPF net income is -$62.9M
Is Mithra Pharmaceuticals SA Growing As A Company?
Data Unavailable
Mithra Pharmaceuticals SA Stock Price Performance
-
Did Mithra Pharmaceuticals SA Stock Go Up Last Month?
Mithra Pharmaceuticals SA share price went up by 0% last month -
Did MITPF's Share Price Rise Over The Last Year?
MITPF share price rose by 0% over the past 1 year
What Is Mithra Pharmaceuticals SA 52-Week High & Low?
-
What Is Mithra Pharmaceuticals SA’s 52-Week High Share Price?
Mithra Pharmaceuticals SA has traded as high as $6.75 over the past 52 weeks -
What Is Mithra Pharmaceuticals SA’s 52-Week Low Share Price?
Mithra Pharmaceuticals SA has traded as low as $6.75 over the past 52 weeks
Mithra Pharmaceuticals SA Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Mithra Pharmaceuticals SA?
-
How Much Debt Does Mithra Pharmaceuticals SA Have?
Total long term debt quarterly is $181.7M -
How Much Cash Does Mithra Pharmaceuticals SA Have?
Cash and short term investments quarterly total is $25.8M -
What Is Mithra Pharmaceuticals SA’s Book Value Per Share?
Book value per share is -0.16
Is Mithra Pharmaceuticals SA Cash Flow Positive?
-
What Is MITPF Cash Flow From Operations?
Cash flow from operations (TTM) is -$8.6M -
What Is Mithra Pharmaceuticals SA’s Cash Flow From Financing?
Cash flow from financing (TTM) is $13.9M -
What Is Mithra Pharmaceuticals SA’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$11.1M
Mithra Pharmaceuticals SA Return On Invested Capital
-
Is Management Doing A Good Job?
MITPF return on invested capital is -40.27% -
What Is Mithra Pharmaceuticals SA Return On Assets?
ROA measures how assets are converting to revenues and is -18.91% -
What Is MITPF Return On Equity?
ROE is a measure of profitability and is -391.67%
Mithra Pharmaceuticals SA Earnings Date & Stock Price
-
What Is Mithra Pharmaceuticals SA's Stock Price Today?
A single share of MITPF can be purchased today for 6.75 -
What Is Mithra Pharmaceuticals SA’s Stock Symbol?
Mithra Pharmaceuticals SA trades on the otcm under the ticker symbol: MITPF -
When Is Mithra Pharmaceuticals SA’s Next Earnings Date?
The next quarterly earnings date for Mithra Pharmaceuticals SA is scheduled on March 7, 2025 -
When Is MITPF's next ex-dividend date?
Mithra Pharmaceuticals SA's next ex-dividend date is November 6, 2024 -
How To Buy Mithra Pharmaceuticals SA Stock?
You can buy Mithra Pharmaceuticals SA shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Mithra Pharmaceuticals SA Competitors
-
Who Are Mithra Pharmaceuticals SA's Competitors?
Below is a list of companies who compete with Mithra Pharmaceuticals SA or are related in some way:
Mithra Pharmaceuticals SA Dividend Yield
-
What Is MITPF Dividend Yield?
Mithra Pharmaceuticals SA’s dividend yield currently is 0% -
What Is Mithra Pharmaceuticals SA’s Payout Ratio?
Mithra Pharmaceuticals SA’s payout ratio is 0% -
When Did Mithra Pharmaceuticals SA Last Pay A Dividend?
The latest dividend pay date is November 6, 2024 -
What Is Mithra Pharmaceuticals SA’s Dividend Per Share?
Mithra Pharmaceuticals SA pays a dividend of $0.00 per share
Mithra Pharmaceuticals SA Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 0% |
| Revenue: | 0% | 0% |
Analyst Recommendations
| Buy Recommendations: | 0 |
|---|---|
| Hold Recommendations: | 0 |
| Sell Recommendations: | 0 |
| Price Target: | 0.00 |
| Downside from Last Price: | -100% |